in Synechocystis, respectively. Insertion of the constructs "MrBBS:GS:Strep: T1/ T7Te " and "PcPS:GS:Strep: T1/ T7Te " into the pSHDY_in_PpetE:BCD2 backbone was conducted via NheI (2 nd /3 rd codon of CDS) and PstI (downstream of double terminator rrnB T1/ T7Te), using pSHDY-in_PpetE:BCD2:mVenus as cloning template. Construct "AgBIS:AGS:Flag:T1/ T7Te" was inserted via SpeI and PstI, thereby destroying the compatible NheI site in the template. Gene expression in Synechocystis was mediated by the native copper-inducible promoter PpetE and the 5'UTR BCD2, harboring an insulated translation initiation feature 3 . Transcription terminates at the double terminator B0015 (rrnB T1/ T7Te). For improved insulation of the PpetE:BCD2 expression module, B0015 and a non-sense 200-bp spacer 1 
Material and Methods

Extraction and quantification of sesquiterpenoids from cell pellets and growth media
For initial fractionation of HDC cultures into cell pellets and media supernatant, each 4 mL of cell cultures from tp 96h of HDC were spun down for 10 min at 5000 g and 4 °C (Centrifuge 5804R, Rotor A-4-44, Eppendorf). The supernatants were transferred to fresh tubes and centrifuged again (10 min, 5000g, 4 °C). Each 3 mL of the supernatant were subjected to terpenoid extraction by adding 250 µL dodecane (incl. 2.5 µg * mL -1 BCP as IS and 0.05% butylated hydroxytoluene (BHT) as antioxidant); samples were vigorously vortexed for 15 sec and further agitated overnight in a horizontal position at ~90 rpm on an orbital shaker. The samples were centrifuged (10 min at 5000 g, RT) and each 200 µL of the dodecane overlay were subjected to GC-FID analysis (cf. main text).
Pellets were resuspended in fresh 1 mL thylakoid buffer (cf. main text). Equivalents of each 50 OD units were diluted in thylakoid buffer to a final volume of 400 µL. To correct for variations in the extraction efficiency, each 4 µL BCP (25 mg *mL -1 ) were added as IS before extraction, which would correspond to a final concentration of 2.5 µg * mL -1 BCP in the extraction solvent (dodecane), given that the efficiency equals 100%. A volume of ~200 µL 425-600 µm glass beads (acid-washed, 20-40 U.S. sieve, Sigma) was added and samples were homogenized using a Precellys24 tissue homogenizer (Bertin technologies) for 2 x 30 s at 5600 rpm with a 2 min interval. For extraction, each 400 µL dodecane (incl. 0.05% butylated hydroxytoluene (BHT) as antioxidant) were added; the samples were vigorously vortexed for 15 sec and agitated overnight in a horizontal position at ~90 rpm on an orbital shaker. The samples were centrifuged (5 min at 13000 g, RT) and each 200 µL of the dodecane overlay were subjected to GC-FID analysis (cf. main text).
Terpenoid yields were calculated based on GC-FID data as product titer in the culture [mg L -1 ]. For peak area [µV·s] normalization individual values were divided by the corresponding IS peak area and multiplied with the mean IS value of all biological and ES samples. Raw volumetric concentrations [µg * mL -1 ] were calculated with the linear equation from ES calibration charts derived from the same GC cycle. For bisabolene, each value was further multiplied with factor 0.2752, to correct for impurities of the commercial standard. The mean raw concentration of all blank samples from the same run were subtracted from each value. The total concentration in the supernatant extracts was extrapolated with the corresponding scale factor (e.g. (10 µg * mL -1 * 0.25/1000) = 0.00025 mg * 0.25 mL -1 extract). This value was divided by the actual culture volume and multiplied with factor 1000 to extrapolate the final product titer [mg * L -1 ]. The total concentration in the cellular extracts was extrapolated with the corresponding scale factor (e.g. (10 µg * mL -1 * 0.4/1000) = 0.004 mg * 0.4 mL -1 extract). This value was multiplied with the the quotient of the individual dilution factor (i.e. normalization to OD 50 in 400 µL buffer) divided by the concentration factor 4 (pellet from 4 mL culture resuspended in 1 mL buffer), which was further multiplied with factor 10 (to convert µg * 400µL -1 extract to µg * 4 mL -1 culture Vol.). Example: (0.004 mg * 0.4 mL -1 extract) * individual dilution factor 1.25 = 0.05 mg * 0.4 mL -1 extract; (0.05 mg * 0.4 mL -1 extract) / concentration factor 4 = 0.00125 mg * 0.4 mL -1 extract; (0.00125 mg * 0.4 mL -1 extract) * factor 10 = 0.0125 mg * 4 mL -1 culture. To extrapolate the final product titer [mg * L -1 ], this value was eventually divided by 4 (mL culture sample volume), multiplied with factor 1000 (conversion of mg * mL -1 to mg * L -1 ) and corrected for evaporation (multiplication with evaporation factor = actual Vol./ theoretical Vol.). Example: (0.0125 mg * 4 mL -1 culture)/ 4 = 0.003125 mg * mL -1 culture; 0.003125 mg * mL -1 extract * 1000 = 3.125 mg * L -1 culture; 3.125 mg * L -1 culture * (8 mL/ 6 mL) = 4.1666 mg * L -1 culture
